# Introduction very woman wishes to have a healthy pregnancy which culminates in a healthy baby and a healthy mother. Unfortunately, some women develop dreaded complications that may result in adverse obstetric outcomes. These include Hypertensive disorders of pregnancy, Pre-eclampsia, Eclampsia and HELLP syndrome 1 . Pre-eclampsia occurs in 5-10% of pregnancies 2 . The HELLP syndrome (haemolysis, elevated liver enzymes, and low platelets) is a variant of severe pre-eclampsia that is associated with significant maternal and perinatal morbidity and mortality 3 . HELLP syndrome develops in 6-12% of women with preeclampsia or eclampsia accounting for 0.4-0.7% of all pregnancies 4 . Maternal mortality is due to consequences such as pulmonary oedema, renal failure, disseminated intravascular coagulation and subcapsular liver hematoma 5 . Perinatal mortality appears to be primarily related to the Maternal and Perinatal Outcome in Patients with HELLP Syndrome gestational age at the time of delivery 6 . HELLP syndrome is regarded as high risk for the mother and neonate compared to pre-eclampsia. Early diagnosis and identification of complication of HELLP syndrome and timely intervention form the main strategy of management. 7 II. # Aims and Objectives of the # Methodology This was prospective observational study done over a period of 24 months i.e., Nov. 2015 to Oct. 2017. Total 56 cases of HELLP syndrome were studied. This study was conducted in department of obstetrics and gynaecology of medical college and tertiary health care centre # a) Inclusion Criteria ? All antenatal patients with pre-eclampsia and eclampsia complicated with HELLP syndrome. # b) Exclusion Criteria ? All patients with chronic hypertension IV. # Results The following data was obtained from the present series of 56 cases studied at tertiary care hospital, in department of obstetrics and gynaecology from 30th November, 2015 to 31st October, 2017. 2). # Table 3: No. of cases according to parity In present study 58.93% were primigravidae, while 41.07% of patients were multiparous (Table 3). In our study 24 (42.85%) cases of HELLP syndrome were seen of more than 37 weeks of gestation. (Table 4). In present study majority of the patients presented with severe preeclampsia and there were 20 cases (35.71%) with mild pre-eclampsia. Maximum patients i.e., 58.92% of HELLP syndrome had platelet count less than 1lakh/ml. Serum lactate dehydrogenase was raised in all patients with HELLP syndrome. All patients with HELLP syndrome had raised serum AST was 70IU/L.55.36% (31 cases) had bilirubin levels > 1.2 mg/dl while 44.64% (25 cases) had bilirubin levels < 1.2 mg/dl.25% (14 cases) had abnormal renal function parameters.67.86% (38 cases) had serumuric acid levels > 6 mg/dl 33 cases (58.93%) required transfusion of blood or components while 23 cases (41.07%) did not require any blood and blood products. # Discussion HELLP syndrome is life threatening complication considered to be variant of preeclampsia and eclampsia. Early identification of risk factors in pregnancy and timely intervention gives better maternal and perinatal outcome. In our study mean maternal age was 23.09 ± 4.45 (18-35 years) which was comparable to James N Martin et al., 8 (1991) 22.9 ± 5.5 (14-42 years). Majority of the patients in the present study were primigravidas (33 cases) 58.93% comparable to Sibai BM Taslim et al., 2 (1986) In this present study transfusion of bold and blood products wasrequired in 58.93% which was comparable with Imir GA 10 62.5% and higher than Vigil Pde Gracia 7 29%. In the present study, DIC 19.64% was lesser than Ahmed et al., 13 In this present study, maternal mortality was 14.28% and was higher than Imir GA 10 7.8% and Ahmed et al., 13 # Conclusion In our study done over a period of 2 years, there were 56 cases of HELLP syndrome. Once the diagnosis of HELLP syndrome has been made, it warrants aggressive intervention with control of blood pressure, antiseizureprophyl axis, corticosteroid treatment for fetal lung maturity and expeditious delivery. HELLP syndrome, among pre-eclampsia and eclampsia cases is associated with significant maternal morbidity and mortality and perinatal mortality and morbidity. The present study shows maternal mortality of 14.28% but still perinatal mortality constitutes 46.43%. In order to reduce the maternal and perinatal mortality, It is highly desirable that obstetric care providers at all levels become knowledge able about the early diagnosis and management of HELLP syndrome. We have to intensify our efforts to reduce preeclampsia with HELLP syndrome from the grass root level with regular antenatal care, early detection of preeclampsia and its prompt management and early detection of complications with timely intervention. This will go a long way in preventing this catastrophic disease. Vigilant fetal monitoring (including electronic fetal monitoring), prompt timely intervention at the periphery and improvement of neonatal care facilities with good prenatal care at the foremost are needed to reduce the perinatal mortality in the present study. 1classification of HELLP as per Mississippi'sclassification ClassMajority of the cases belonged to class II andclass III HELLP, 23 each (41.07%) followed by class IHELLP, 10 (17.86%). 248.21% of cases were in the age group 20-24years (Table 4Year 202112 5Clinical signs Class 1Class 2 Class 3 Total%Mild28102035.71%BPSevere815133664.29 6 7 8 9a 9bMaternal and Perinatal Outcome in Patients with HELLP SyndromeClass 1 Class 2 Class 3 Total%Anemia4531221.43Pum edema11023.57Resp infection11023.57Oliguria11023.57Hematuria11135.36Renal failure430712.50Abruption431814.29DIC8301119.64plateletClass 1 Class 2 Class 3 10 23 23Ascites sepsis Death0 1 21 1 41 0 22 2 83.57 3.57 14.2813 Year 2021LDH >600 IU/L AST/>70 IU/L UA>6mg Bilirubin >1.2 Srcreat>1.2mg/dl Blood and blood products Transfusion Class 125 30 8 8 5 Class 220 16 15 14 4 Class 311 10 15 9 5 Grand Total%Pre Term APGAR <6 IUGR MAS Sept NICU admissionClass 1 11 16 9 3 0 11 Class 1 Class 2 Class 3 Total Class 2 Class 3 Grand Total 10 5 26 12 7 35 7 1 17 2 2 7 1 0 1 10 4 25% 46.43% 62.50% 30.36% 12.50% 1.79% 44.64% %Volume XXI Issue I Version I ( D D D D ) ENot Transfused Transfused Grand Total0 10 108 15 2315 8 2323 33 5641.07% 58.93% 100.00%Live birth Still birth IUFD END Take home6 3 1 1 517 5 1 3 1413 6 4 2 1136 14 6 6 3064.29 25.00 10.71 10.71 53.57Medical ResearchV.Global Journal of© 2021 Global Journals 10Year 202114 11ComplicationsKim YH 6Sibai BM et al 2Svendson HK 14Imir GA 10Present studyNICU admission85.7%28.3%--44.64%Preterm--70%-46.43%IUGR47.6%31.6%38.6%54.7%30.36%Still birth-19.5%--25%IUD4.8%--18.8%10.71%APGAR <666.7%28.5%-37.5%62.5%RDS38.1%-40%23.4%-Sepsis85.7%--7.8%1.79%Neonatal death19.5%17.4%-20.3%10.71%Shafika Banoo 15 40% and Hadded et al., 12 63%. Majorityof the indication for cesarean section were fetal distress,CPD, previous cesarean section and worseningmaternal parameters with failed induction. Cesarean delivery in present study was 16.07%which was lesser than Vigil P de Gracia 7 71% and15 VI. * LWeinstein Hellp Am J Obstet Gynecol 9 1982 * Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes and low platelets in sever preeclampsia-eclampsia BMSibai MMTaslimi AEl-Nazer ErolAmon BGMabie GMRegan 10.1016/0002-9378 Am J Obstet Gynecol 155 3 1986 * Pregnancie complicated by HELLP syndrome: Subsequent pregnancy outcome and long-term prognosis BMSibai MKRamadan Am J Obstet Gyneco1 172 1995 * Maternal morbidity and mortality in 442 pregnancies with HELLP syndrome BMSibai MKRamadan IUsta 10.1016/0002-9378(93 Am J Obstet Gyneco1 169 1000 1993 * Joe leigh simpson obstetrics-Normal and problem pregnancies SGGabbe JRNiebyl 2007 5th ed * Neonatal outcome after preterm delivery in HELLP syndrome HYKim YSSohn JHLim 10.3349/ymj.2006.47.3.393 PMC2688160 Yonsei Medical Journal 47 3 2006 * Pregnancy complicated by preeclampsia-eclampsia with HELLP syndrome PVigil DGracia S0020- 7292(00)00281-2 International Journal of Gynecology and Obstetrics 72 2001 * The natural history of HELLP syndrome-patterns of disease progression and regression JNMartinJr PGBlake PerryKgJr 10.1016/0002-9378(91)91429-Z Am J Obstet gynecol 164 1991 * The spectrum of severe preeclampsia, comparative analysis of HELLP (hemolysin, elevated liver enzymes levels and low platelet count) syndrome classification MartinJr JNRinehart BKMay WLMagann EFTerrone DABlake PG S0002-9378(99)70022-0 Am J Obstet Gynecol 180 6 1999 Jun * Perinatal outcomes in HELLP syndrome ImirgAyse KoliOzdemir KKaygusuz ACetin MCetin TgmGonullu J Turkish-German Gynecol Associ 9 2 2008 * Material and neonatal outcomes of HELLP syndrome, A 5-year retrospective analysis. Fernandez Hospital Amithyaa 2010 1 * Risk factors for adverse material outcomes among women with HELLP (hemolysis, elevated liver enzymes and low platelet) syndrome BHadded JRBarton TCLivingston RChahine BSibai 10.1067/mob.2000.105915PMid Am J Obstet Gynecol 183 2 10942484 2000 Aug * HELLP syndrome, A clinical variant of pre-eclampsia FAAhmed AAmin NKNaeem Annals 2007 * The HELLP syndrome, clinical issues and management, A review HKSvendson UAbildgaard 2009 9 * Incidence of HELLP syndrome in sever pregnancy induced hypertension and its impact on maternal and fetal outcome SBanoo TAMakhdoomi SMir JMalik JK Practitioner 14 2 2007 Apr-Jun * Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome AGul ACebeci HAslan IPolat AOzdemivi YCeylan 10.1159/000082648PMid:15591806 Gynecol Obstet Invest 59 2005 * Antipartum corticosteroids; Disease stabilization in patients with the syndrome of HELLP EFMagann DBass SPChauhan 10.1016/0002-9378(94 Am J Obstet Gynecol 171 90054 1994 * Temporising management of severe preeclampsia with and without the HELLP syndrome WVisser HcsWallenburg British Journal of Obstet and Gynecology 102 1995 Feb * 10.1111/j.1471-0528.1995.tb09062.xPMid 7756201